EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies

Steven He iD, Patrick Connerty iD, Antoine de Weck

Medicinal Research Reviews · 2026-07 · 46 (4) · 989-1004

DOI: 10.1002/med.70046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 31.03.2026. Verfasst von Steven He und 2 weiteren Autor:innen. Beteiligte Einrichtung: Children's Cancer Institute, Minderoo Children's Comprehensive Cancer Centre, Sydney, NSW, Australia. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Neoplasms, Genomics, Genome-Wide Association Study. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Council NSW, Cancer Institute NSW, Cancer Institute NSW Research Capacity Building.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR‐Cas9 genome‐wide screening has been instrumental towards identifying novel targets for drug discovery in cancer research. However, much of this research has centred specifically on adult cancers, with paediatric cancers being underserviced by current research and screening. With contemporary evidence increasingly highlighting the differences in biology between adult and children's cancers, more research has gradually occurred investigating dependencies and mechanisms of resistance in paediatric cancers through the use of CRISPR‐Cas9 genome‐wide screens. This review collates and summarises the experimental genome‐wide screens that have been performed specifically in paediatric cancer models, and highlights the versatility of this technology and the knowledge gained through this research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsNeoplasmsGenomicsGenome-Wide Association StudyHumansDrug DiscoveryChildAnimals

Stichwörter der Autor:innen

CRISPR‐Cas9drug discoveryfunctional genomicsgenome‐wide screeningpaediatric cancer

Autor:innen und Institutionen

  • Children's Cancer Institute, Minderoo Children's Comprehensive Cancer Centre, Sydney, NSW, Australia.
  • School of Clinical Medicine, UNSW Sydney, Sydney, NSW, Australia.

ORCID-Profile: Steven He, Patrick Connerty

Förderung

  • Cancer Council NSW
  • Cancer Institute NSW
  • Cancer Institute NSW Research Capacity Building
  • Sydney Partnership for Health, Education, Research and Enterprise

Zitieren

APA

He, S., Connerty, P., & de Weck, A. (2026). CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies. Medicinal Research Reviews, 46(4), 989-1004. https://doi.org/10.1002/med.70046

Vancouver

He S, Connerty P, de Weck A. CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies. Medicinal Research Reviews. 2026;46(4):989-1004. doi:10.1002/med.70046

BibTeX
@article{He2026,
  author = {He, Steven and Connerty, Patrick and de Weck, Antoine},
  title = {CRISPR‐Cas9 Genome‐Wide Screening in Paediatric Cancer: Functional Genomics for Target Discovery and the Improvement of Existing Therapies},
  journal = {Medicinal Research Reviews},
  year = {2026},
  volume = {46},
  number = {4},
  pages = {989--1004},
  doi = {10.1002/med.70046}
}
Kostenlos starten →